300 related articles for article (PubMed ID: 23908537)
21. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group.
Leung YY; Tillett W; de Wit M; Orbai AM; Coates LC; FitzGerald O; Helliwell PS; Strand V; Mease PJ; Goel N; Christensen R; Merola JF; Lindsay CA; Ogdie A; Gossec L; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):53-57. PubMed ID: 37419621
[TBL] [Abstract][Full Text] [Related]
22. Prologue: 2020 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Duffin KC; Gottlieb AB; O'Sullivan D; Gladman DD; McFarland LV
J Rheumatol Suppl; 2021 Jun; 97():1-3. PubMed ID: 34074657
[TBL] [Abstract][Full Text] [Related]
23. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.
Gottlieb AB; Levin AA; Armstrong AW; Abernethy A; Duffin KC; Bhushan R; Garg A; Merola JF; Maccarone M; Christensen R
J Am Acad Dermatol; 2015 Feb; 72(2):345-8. PubMed ID: 25486914
[TBL] [Abstract][Full Text] [Related]
24. Prologue: 2021 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Duffin KC; Gladman DD; Goel N; Gottlieb AB; FitzGerald O; McFarland LV
J Rheumatol; 2022 Jun; 49(6 Suppl 1):1-3. PubMed ID: 35169061
[TBL] [Abstract][Full Text] [Related]
25. Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting.
Callis Duffin K; Armstrong AW; Mease PJ
J Rheumatol; 2012 Nov; 39(11):2198-200. PubMed ID: 23118287
[TBL] [Abstract][Full Text] [Related]
26. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting.
Duffin KC; Garg A; Armstrong AW; Helliwell P; Mease PJ
J Rheumatol; 2014 Jun; 41(6):1240-3. PubMed ID: 24882862
[TBL] [Abstract][Full Text] [Related]
27. Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
Leung YY; Orbai AM; Tillett W; Ogdie A; Eder L; Goel N; Hojgaard P; Holland R; Mathew AJ; Lindsay CA; Antony A; Chau J; Christensen R; Coates LC; Mease PJ; Strand V; FitzGerald O; de Wit M; Duffin KC; Gladman DD
J Rheumatol Suppl; 2021 Jun; 97():60-63. PubMed ID: 34074670
[TBL] [Abstract][Full Text] [Related]
28. Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting.
Yousif JE; Merola JF; Perez-Chada LM; Zagona-Prizio C; Armstrong AW; Ogdie A; Shin S; Gottlieb AB
J Rheumatol; 2022 Jun; 49(6 Suppl 1):40-43. PubMed ID: 35365577
[TBL] [Abstract][Full Text] [Related]
29. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
30. Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.
Okhovat JP; Ogdie A; Reddy SM; Rosen CF; Scher JU; Merola JF
J Rheumatol; 2017 May; 44(5):693-694. PubMed ID: 28461529
[TBL] [Abstract][Full Text] [Related]
31. Summary of minutes of the GRAPPA meeting adjacent to the American Academy of Dermatology 67th Annual Meeting.
Boehncke WH; Gottlieb AB; Krueger GG; Qureshi AA; Garg A
J Rheumatol; 2011 Mar; 38(3):553-6. PubMed ID: 21362786
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome measures of psoriasis.
Bonifati C; Berardesca E
Reumatismo; 2007; 59 Suppl 1():64-7. PubMed ID: 17828348
[TBL] [Abstract][Full Text] [Related]
33. Prologue: 2019 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Goel N; Gottlieb AB
J Rheumatol Suppl; 2020 Jun; 96():1-3. PubMed ID: 32482760
[TBL] [Abstract][Full Text] [Related]
34. Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.
Ogdie A; de Wit M; Callis Duffin K; Campbell W; Chau J; Coates LC; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; James J; Kalyoncu U; Latella J; Lindsay C; Mease PJ; O'Sullivan D; Steinkoenig I; Strand V; Tillett W; Orbai AM
J Rheumatol; 2017 May; 44(5):697-700. PubMed ID: 28461531
[TBL] [Abstract][Full Text] [Related]
35. GRAPPA Trainees Symposium 2015: A Report from the GRAPPA 2015 Annual Meeting.
Milliken M; Generali E; Marin J; Ritchlin CT
J Rheumatol; 2016 May; 43(5):952-8. PubMed ID: 27134268
[TBL] [Abstract][Full Text] [Related]
36. The GRAPPA-OMERACT Working Group: 4 Prioritized Domains for Completing the Core Outcome Measurement Set for Psoriatic Arthritis 2019 Updates.
Leung YY; Tillett W; Orbai AM; Ogdie A; Eder L; Coates LC; Holland R; Antony A; Goel N; Mease PJ; Strand V; FitzGerald O; de Wit M; Lindsay CA; Callis Duffin K; Gladman DD
J Rheumatol Suppl; 2020 Jun; 96():46-49. PubMed ID: 32482768
[TBL] [Abstract][Full Text] [Related]
37. Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.
Orbai AM; Mease PJ; de Wit M; Kalyoncu U; Campbell W; Tillett W; Eder L; Elmamoun M; FitzGerald O; Gladman DD; Goel N; Gossec L; Lindsay CA; Steinkoenig I; Helliwell PS; McHugh NJ; Strand V; Ogdie A
J Rheumatol; 2016 May; 43(5):965-9. PubMed ID: 27134271
[TBL] [Abstract][Full Text] [Related]
38. GRAPPA Trainees Symposium 2012: a report from the GRAPPA 2012 annual meeting.
Garg N; Touma Z; Ritchlin CT
J Rheumatol; 2013 Aug; 40(8):1413-8. PubMed ID: 23908535
[TBL] [Abstract][Full Text] [Related]
39. Assessing disease activity in psoriasis and psoriatic arthritis: impact on management and therapy.
Chandran V; Maharaj AB
Expert Rev Clin Immunol; 2016; 12(5):573-82. PubMed ID: 26807494
[TBL] [Abstract][Full Text] [Related]
40. Practical Assessment of Psoriasis Clinical Severity in both Clinical Trials and Clinical Practice Settings: A Report from the GRAPPA 2016 Annual Meeting.
Merola JF; Gottlieb AB
J Rheumatol; 2017 May; 44(5):691-692. PubMed ID: 28461528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
